Neuralink Prepares Human Trials for Thought-to-Text Interface
Key Takeaways Neuralink is set to begin a US clinical trial in October to translate thoughts into text. The FDA approved the trial under an investigational device exemption, aiming to assist those with speech impairments. DJ Seo stated that the technology could enable communication with AI “at the speed of thought,” surpassing spoken speed. The…